Nanobiotix S.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Aug 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Feb 8 to 27, 2027 · next Feb 8
- 1 fee due Mar 17, 2027The maintenance fee for Pharmaceutical composition, preparation and uses thereof (US 10,413,509) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Apr 20, 2027The maintenance fee for Activatable particles, preparations and uses (US 9,162,079) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
- 1 fee due May 21, 2027The maintenance fee for Inorganic Nanoparticles Compositions in Combination with Ionizing Radiations for Treating Cancer (US 11,819,548) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,700,621 | Metallic nanoparticles, preparation and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,391,174 | Metallic nanoparticles, preparation and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,162,079 | Activatable particles, preparations and uses In force · From the USPTO record | In force | From the USPTO record | |
| US 8,845,507 | Inorganic nanoparticles of high density to destroy cells in-vivo In force · From the USPTO record | In force | From the USPTO record | |
| US 10,064,962 | Method of Monitoring the Release from Liposomes of a Product of Interest Using Superparamagnetic Nanoparticles In force · Medium confidence | In force | Medium confidence | |
| US 11,020,480 | Inorganic Nanoparticles Compositions in Combination with Ionizing Radiations for Treating Cancer In force · High confidence | In force | High confidence | |
| US 11,819,548 | Inorganic Nanoparticles Compositions in Combination with Ionizing Radiations for Treating Cancer In force · High confidence | In force | High confidence | |
| US 12,653,890 | Inorganic Nanoparticles Compositions in Combination with Ionizing Radiations for Treating Cancer In force · High confidence | In force | High confidence | |
| US 11,357,724 | Pharmaceutical composition, preparation and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,098,952 | Inorganic Nanoparticles Compositions in Combination with Ionizing Radiations for Treating Cancer In force · High confidence | In force | High confidence |
Also on record, not counted in the 25: 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded